Table 2 Neuropsychiatric assessment
From: Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?
Neuropsychiatric assessment | ME/CFS (n = 42) RS M (SD) | Post-COVID-19 condition (n = 73) RS M (SD) | Statistics |
|---|---|---|---|
Health perception (SF-36) | |||
Physical functioning | 32.14 (21.24) | 49.21 (24.71) | t = 3.74*** |
Limitations due to physical problems | 9.22 (14.16) | 22.22 (29.23) | U = 2077.50* |
Pain | 27.67 (30.18) | 33.28 (24.64) | U = 1248.00 |
Social role | 13.27 (22.27) | 32.46 (30.45) | U = 881.00*** |
Mental health | 49.64 (24.99) | 60.63 (25.04) | U = 1141.00* |
Limitations due to emotional problems | 61.50 (33.58) | 73.13 (29.85) | U = 1220.50 |
Energy, fatigue | 9.37 (12.51) | 15.90 (15.81) | U = 1111.50* |
Health perception | 23.39 (16.34) | 38.13 (21.29) | U = 881.50*** |
Sleep quality | |||
PSQI | 12.85 (5.04) | 11.26 (4.64) | U = 1752.50 |
Fatigue | |||
MFIS | 68.09 (12.74) | 62.68 (15.41) | U = 1847.50 |
Performance status | |||
Karnofsky scale | 68.09 (8.33) | 73.97 (8.93) | U = 1025.00*** |
Depression | |||
GDS | 9.35 (3.21) | 6.97 (3.97) | U = 2070.50** |
Suicidal ideation | |||
C-SSRS | 0.83 (1.32) | 0.24 (0.66) | U = 1906.50** |
Anxiety (STAI) | |||
Anxiety trait | 26.97 (17.12) | 27.12 (14.12) | U = 1133.50** |
Anxiety state | 31.42 (15.32) | 17.08 (14.04) | t = − 1.52 |